Evaluation of the treatment of severe forms of schistosomiasis mansoni with oxamniquine.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D002648:Child; D002908:Chronic Disease; D003110:Colonic Neoplasms / Q000150:complications; D004359:Drug Therapy, Combination; D005260:Female; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D007417:Intestinal Polyps / Q000150:complications; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000008:administration & dosage / Q000627:therapeutic use*; D012480:Salmonella Infections / Q000150:complications; D012552:Schistosomiasis / Q000145:classification / Q000150:complications / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D009600:Nitroquinolines; D010073:Oxamniquine